D. Andrew Burden
- Molecular Biology top 10%
- Oncology top 10%
- Toxicology top 0.5%
- Organic Chemistry top 10%
- Pharmacology
- Co-authors
- Neil OsheroffPaul S. KingmaStacie J. Froelich-AmmonDaniel M. SullivanN.C. HammetMarcia W. PatchanRichard B. ThompsonMary‐Ann Bjornsti
- Topics
- Cancer therapeutics and mechanisms (12 papers)Bioactive Compounds and Antitumor Agents (5 papers)DNA and Nucleic Acid Chemistry (3 papers)
- Cited by
- ToxicologyMolecular BiologyOncology
- Partner nations
- United StatesJapan
In The Last Decade
D. Andrew Burden
15 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 848
- Oncology 332
- Toxicology 221
- Organic Chemistry 193
- Pharmacology 75
Countries citing papers authored by D. Andrew Burden
This map shows the geographic impact of D. Andrew Burden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Andrew Burden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Andrew Burden more than expected).
Fields of papers citing papers by D. Andrew Burden
This network shows the impact of papers produced by D. Andrew Burden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Andrew Burden. The network helps show where D. Andrew Burden may publish in the future.
Co-authorship network of co-authors of D. Andrew Burden
This figure shows the co-authorship network connecting the top 25 collaborators of D. Andrew Burden. A scholar is included among the top collaborators of D. Andrew Burden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Andrew Burden. D. Andrew Burden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 59 | |
| 2 | 38 | |
| 3 | 71 | |
| 4 | 22 | |
| 5 | 47 | |
| 6 | 53 | |
| 7 | 435 | |
| 8 | 35 | |
| 9 | 129 | |
| 10 | Pharmacokinetics and metabolism of a new cartilage protective agent | 1 |
| 11 | 10 | |
| 12 | 31 | |
| 13 | 43 | |
| 14 | 27 | |
| 15 | 23 |
About D. Andrew Burden
D. Andrew Burden is a scholar working on Toxicology, Molecular Medicine and Pharmacology, having authored 15 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (12 papers), Bioactive Compounds and Antitumor Agents (5 papers) and DNA and Nucleic Acid Chemistry (3 papers). The work is most often cited by research in Toxicology (221 citations), Molecular Biology (848 citations) and Oncology (332 citations). D. Andrew Burden has collaborated with scholars based in United States and Japan. Frequent co-authors include Neil Osheroff, Paul S. Kingma, Stacie J. Froelich-Ammon, Daniel M. Sullivan, N.C. Hammet, Marcia W. Patchan, Richard B. Thompson, Mary‐Ann Bjornsti, Ryan Bender and R. Hunter Lindsey. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.